AdvanSix (ASIX) to Release Earnings on Friday

AdvanSix (NYSE:ASIX) is expected to post its quarterly earnings results before the market opens on Friday, February 21st. Analysts expect AdvanSix to post earnings of ($0.37) per share and revenue of $377.15 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

AdvanSix Trading Down 0.4 %

ASIX opened at $30.30 on Thursday. AdvanSix has a 12 month low of $20.86 and a 12 month high of $33.00. The stock has a market capitalization of $809.89 million, a price-to-earnings ratio of 21.49 and a beta of 1.76. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.34 and a quick ratio of 0.62. The business has a fifty day moving average price of $29.69 and a 200 day moving average price of $29.72.

Wall Street Analyst Weigh In

ASIX has been the subject of a number of analyst reports. StockNews.com upgraded shares of AdvanSix from a “hold” rating to a “buy” rating in a research note on Wednesday, December 4th. Piper Sandler upped their price objective on AdvanSix from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, November 8th.

Insider Activity at AdvanSix

In related news, CEO Erin N. Kane sold 5,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $30.19, for a total value of $150,950.00. Following the completion of the sale, the chief executive officer now directly owns 502,795 shares of the company’s stock, valued at $15,179,381.05. This represents a 0.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christopher Gramm sold 1,951 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $32.00, for a total value of $62,432.00. Following the completion of the sale, the insider now directly owns 43,463 shares of the company’s stock, valued at approximately $1,390,816. This trade represents a 4.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,951 shares of company stock valued at $354,132 over the last three months. 5.60% of the stock is owned by corporate insiders.

AdvanSix Company Profile

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.